Similar articles

• Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by alpha-methyl-m-tyrosine.

  Fuller RW, Hemrick-Luecke SK. Fuller RW, et al. Res Commun Chem Pathol Pharmacol. 1983 Jul;41(1):169-72. Res Commun Chem Pathol Pharmacol. 1983. PMID: 6604933
• Amphetamine's locomotor-stimulant and noreprinephrine-releasing effects: evidence for selective antagonism by nisoxetine.

  Tyler TD, Tessel RE. Tyler TD, et al. Psychopharmacology (Berl). 1979 Sep;64(3):291-6. doi: 10.1007/BF00427512. Psychopharmacology (Berl). 1979. PMID: 41278 No abstract available.
• Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.

  Fuller RW, Snoddy HD, Molloy BB. Fuller RW, et al. Psychopharmacol Commun. 1975;1(5):455-64. Psychopharmacol Commun. 1975. PMID: 1228825
• Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain.

  Fuller RW, Perry KW. Fuller RW, et al. Biochem Pharmacol. 1981 Jul 15;30(14):2025-6. doi: 10.1016/0006-2952(81)90215-x. Biochem Pharmacol. 1981. PMID: 7271892 No abstract available.
• dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart.

  Wong DT, Horng JS, Bymaster FP. Wong DT, et al. Life Sci. 1975 Sep 1;17(5):755-60. doi: 10.1016/0024-3205(75)90531-7. Life Sci. 1975. PMID: 1207394 No abstract available.